Companies
SA
STOXX 600Health Care· Germany
SRES
Status-Quo-PlayerSartorius Stedim Biotech
$186.70
-1.06%
Open $186.00·Prev $188.70
Delayed
STATUS-QUO-PLAYER
Power Core
The Power Core is regulatory validation lock-in: once a biologic drug is approved on a Sartorius Stedim consumable specification, switching that consumable out triggers a regulatory change control filing with re-validation risk.
Published20 Apr 2026
UniverseSTOXX 600
SectorHealth Care
↑
Direction of Movement
lateral
ROC 200
-11.2%
SRES
Sartorius Stedim Biotech
$186.70
-1.06%
Open $186.00·Prev $188.70
Delayed
↓Overvalued by 600%
DCF Fair Value: $26.67
News
No recent news available.
mOS zones are proprietary L17X overlays and do not constitute trading signals or investment advice.